Xerox Holdings financials
$3.21−1.53%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $7.02B | $6.22B | $6.89B | $7.11B | $7.04B | $7.02B | $9.07B |
| Gross profit | $1.90B | $1.96B | $2.31B | $2.32B | $2.40B | $2.63B | $3.65B |
| Gross margin | 27.1% | 31.5% | 33.6% | 32.6% | 34.1% | 37.4% | 40.3% |
| Operating income | -$132.0M | -$1.01B | $179.0M | -$325.0M | -$472.0M | $270.0M | $834.0M |
| Net income | -$1.04B | -$1.33B | -$13.0M | -$336.0M | -$469.0M | $178.0M | $1.34B |
| Net margin | −14.9% | −21.5% | −0.2% | −4.7% | −6.7% | 2.5% | 14.8% |
| Diluted EPS | $-8.25 | $-10.75 | $-0.09 | $-1.43 | $-1.71 | $0.56 | $3.87 |
| EBITDA | $265.0M | $433.0M | $597.0M | $422.0M | $674.0M | $731.0M | $1.49B |
| Operating cash flow | $224.0M | $511.0M | $686.0M | $159.0M | $629.0M | $548.0M | $1.33B |
| Free cash flow | $133.0M | $467.0M | $649.0M | $102.0M | $561.0M | $474.0M | $1.27B |
| Diluted shares | 126.5M | 124.2M | 149.1M | 234.0M | 274.8M | 317.2M | 349.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $512.0M | $576.0M | $519.0M | $1.04B | $1.84B | $2.63B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $4.25B | $3.40B | $3.28B | $3.73B | $4.25B | $4.44B |
| Total assets | $9.82B | $8.37B | $10.01B | $11.54B | $13.22B | $14.74B |
| Total liabilities | $9.15B | $7.06B | $7.24B | $7.97B | $8.56B | $8.93B |
| Shareholders' equity | $449.0M | $1.09B | $2.56B | $3.36B | $4.44B | $5.60B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology